Paradice Investment Management LLC Buys 30,949 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Paradice Investment Management LLC lifted its stake in Avanos Medical, Inc. (NYSE:AVNS) by 2.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,293,198 shares of the company’s stock after purchasing an additional 30,949 shares during the period. Avanos Medical accounts for approximately 4.1% of Paradice Investment Management LLC’s holdings, making the stock its 14th largest holding. Paradice Investment Management LLC owned about 2.81% of Avanos Medical worth $20,588,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in AVNS. Geode Capital Management LLC raised its stake in Avanos Medical by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock worth $25,337,000 after buying an additional 16,065 shares during the period. Tributary Capital Management LLC raised its stake in Avanos Medical by 38.1% during the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company’s stock worth $14,217,000 after buying an additional 246,379 shares during the period. Principal Financial Group Inc. raised its stake in Avanos Medical by 3.5% during the 4th quarter. Principal Financial Group Inc. now owns 237,794 shares of the company’s stock worth $3,786,000 after buying an additional 7,932 shares during the period. Foundry Partners LLC raised its stake in Avanos Medical by 1.1% during the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock worth $3,918,000 after buying an additional 1,800 shares during the period. Finally, Empowered Funds LLC raised its stake in Avanos Medical by 141.3% during the 4th quarter. Empowered Funds LLC now owns 153,834 shares of the company’s stock worth $2,449,000 after buying an additional 90,091 shares during the period. 95.17% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Stock Performance

AVNS opened at $16.55 on Tuesday. The business’s 50-day moving average price is $16.45 and its two-hundred day moving average price is $20.05. Avanos Medical, Inc. has a 1 year low of $14.98 and a 1 year high of $25.36. The company has a market capitalization of $760.64 million, a price-to-earnings ratio of 48.68 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.